| Literature DB >> 32390843 |
Shi-Yu Chen1, Yue Gao1, Jia-Yi Sun2, Xian-Li Meng2, Dong Yang1, Lin-Hong Fan1, Li Xiang2, Ping Wang1.
Abstract
Alzheimer's disease (AD) is a progressive age-related neurodegenerative disease characterized by memory loss and cognitive impairment. The major characteristics of AD are amyloid β plaques, apoptosis, autophagy dysfunction, neuroinflammation, oxidative stress, and mitochondrial dysfunction. These are mostly used as the significant indicators for selecting the effects of potential drugs. It is imperative to explain AD pathogenesis and realize productive treatments. Although the currently used chemical drugs for clinical applications of AD are effective in managing the symptoms, they are inadequate to achieve anticipated preventive or therapeutic outcomes. There are new strategies for treating AD. Traditional Chinese Medicine (TCM) has accumulated thousands of years of experience in treating dementia. Nowadays, numerous modern pharmacological studies have verified the efficacy of many bioactive ingredients isolated from TCM for AD treatment. In this review, representative TCM for the treatment of AD are discussed, and among these herbal medicines, the Lamiaceae family accounts for the highest proportion. It is concluded that monomers and extracts from TCM have potential therapeutic effect for AD treatment.Entities:
Keywords: Alzheimer’s disease; apoptosis; autophagy; mitochondrial dysfunction; neuroinflammation; oxidative stress; traditional Chinese medicine; β-amyloid
Year: 2020 PMID: 32390843 PMCID: PMC7188934 DOI: 10.3389/fphar.2020.00497
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
Figure 1Schematic diagram depicting the pathogenesis of AD. Aβ generated from its precursor APP processing via cleavage by β-secretase and γ-secretase. Aβ deposition would cause senile plaque and further tau phosphorylation and aggregation to form NFTs, which lead to the loss of neurons and synaptic dysfunction. In addition, Aβ deposition induce mitochondrial injury and trigger ER stress, causing neuronal cell death.
Figure 2Schematic diagram of autophagy, neuroinflammation, oxidative stress, mitochondrial dysfunction and apoptotic in AD. Autophagy is positive in alleviating AD through promoting Aβ degradation, but hyperactive autophagy is harmful to neuron survival (A). The depositions of Aβ activates the astrocytes and microglia which would secrete oxidative species, such as nitric oxide, and pro-inflammatory cytokines (B). Cytokines on the cell surface and activate pro-apoptotic signaling cascades. Mitochondrial dysfunction cause mitochondria to produce elevated levels of reactive oxygen and nitrogen species (ROS and RNS). Enhancement of ROS and RNS aggravates mitochondrial dysfunction (C, D), finally causing release of the pro-apoptotic signaling protein, CytC. CytC contributes to formation of the apoptosome (D). These factors all cause death of neuronal populations and lead to neurodegenerative disease.
TCM for treating AD by reducing β-Amyloid production.
| Numbers | Compounds | Chemistry structure | Dosages | Activities | Molecular mechanism | Models | References |
|---|---|---|---|---|---|---|---|
| 1 | Ginseng protein | — | 0.05–0.1 g/kg twice daily | Improve the memory ability and cognitive and reduce Aβ production | Inhibit Aβ1-42 and p-tau and increase the mRNA and PI3K, p-Akt/Akt, and Bcl-2/Bax |
|
|
| 2 | — | 200 mg/kg | Reduce Aβ deposition and insoluble Aβ levels | Attenuate Aβ-induced toxicity through anti-amyloidogenesic and neurotrophic pathways | Heterozygous APPswe/PS1Δ9 transgenic founder mice |
| |
| 3 | Safflower yellow |
| 10–30 mg/kg | Improve cognitive function and ameliorate the learning and memory deficits | Decrease Aβ accumulation and overactivation of astrocytes | APP/PS1 transgenic mice |
|
| 4 | Emodin |
| 80 mg/kg/day | Improve the memory ability and cognitive, reduce Aβ production | Reduce the levels of Aβ and tau phosphorylation | Hyperhomocysteinemia (HHcy) induced rats |
|
| 5 | Onjisaponin B |
| 1mg/mL, 200μL | Suppress Aβ production, improve learning and memory capacity | Suppress Aβ production promoted the degradation of APP | The APPswe/PS1ΔE9 (APP/PS1) double-transgenic mice |
|
TCM for treating AD by anti-apoptosis.
| Numbers | Compounds | Chemistry structure | Dosages | Activities | Molecular mechanism | Models | References |
|---|---|---|---|---|---|---|---|
| 1 | Morroniside |
| 100 μM | Inhibit apoptosis | Inhibit apoptosis | PC12 cells |
|
| 2 | Curcumin |
| 12.5–200 μM | Reversal neurotoxicity, inhibit apoptosis | Inhibit apoptosis though p38 MAPK and AKT pathways | PC12 cells |
|
| 3 | Triptolide |
| 10−11 mol/L | Inhibit apoptosis | Inhibit intracellular Ca2+ and apoptosis | PC12 cells |
|
| 4 | Crocin |
| 40 mg/kg | Regulate endoplasmic reticulum stress and apoptosis | Increase the autophagy and apoptosis biomarkers | Male Wistar rats |
|
TCM for treating AD by inducing or attenuating autophagy effect.
| Numbers | Compounds | Chemistry structure | Dosages | Activities | Molecular mechanism | Models | References |
|---|---|---|---|---|---|---|---|
| 1 | Berberine |
| 50–100 mg/kg/day | Promote Aβ clearance, improve learning and memory capacity | Induce autophagy by activating Bcl2/Beclin1 signaling | 3 × Tg-AD mice |
|
| 2 | Andrographolide |
| 20 μM | Decrease cell death | Induce autophagy through activation of the Nrf2-mediated p62 signaling pathway | PC12 cells |
|
| 3 | Geniposide |
| 50 mg/kg/day | Reduce Aβ1–40 level, promote Aβ clearance, improve cognitive function | Induce autophagy by down regulation of mTOR | Age-matched C57BL/6 wild-type (WT) mice or APP/PS1 mice |
|
| 4 | β-asarone |
| 240 μg/mL | Increase cell viability, decrease NSE levels | Attenuate autophagy by Akt-mTOR signaling pathway | PC12 cells |
|
| 5 | Dendrobium nobile Lindl. alkaloids | — | 3.5–350 ng/mL | Inhibit axonal degeneration | Induce autophagy by promoting Beclin1 | Aβ25–35-induced hippocampus primary neuron |
|
| 6 | Euxanthone | — | 30 mg/kg or 60 mg/kg | Attenuate memory and spatial learning dysfunction | Induce autophagy by increasing the expression level of LC3B-II and enhancing the degradation of p62 | Sprague-Dawley rats |
|
TCM for treating AD by anti-neuroinflammation.
| Numbers | Compounds | Chemistry structure | Dosages | Activities | Molecular mechanism | Models | References |
|---|---|---|---|---|---|---|---|
| 1 | Gypenoside |
| 50 μg/mL | Attenuate inflammation | Attenuate Aβ induced inflammation | N9 microglial cells |
|
| 2 | Achyranthes bidentata Blume | — | 50 mg/kg | Improve cognitive function, decrease neuroinflammation | Decrease oxidative stress and neuroinflammation through modulating ERK pathway, NF-κB phosphorylation, and translocation | Male Sprague-Dawley rats |
|
| 3 | Matrine |
| 10–50 μM | Improve cognitive deficits and learning ability | Decrease neuroinflammation though Aβ/RAGE signaling pathway | SH-SY5Y cells |
|
| 4 | Loganin |
| 10–30 μM | Decrease neuroinflammation | Decrease neuroinflammation | BV-2 microglia cells |
|
| 5 | Scutellarein |
| 50 mg/kg, intraperitoneally | Suppress neuroinflammation | Increase Bcl-2 and suppress Beclin-1 expression | PC12 cells, male Wistar rats |
|
| 6 | Oridonin |
| 10 mg/kg/day, i.p. for 15 days | Inhibit glial activation, decrease the release of inflammatory cytokines and attenuate memory deficits | Attenuate Aβ1–42-induced neuroinflammation and inhibits NF-κB pathway | Male C57BL/6 (B6) mice |
|
| 7 | Hydroxy-safflor yellow A |
| 20 mg/kg per day, i.p. | Ameliorate the memory deficits and decrease the mRNA expression of pro-inflammatory mediators | Attenuate Aβ1-42-induced inflammation by modulating the JAK2/STAT3/NF-κB pathway | Male ICR mice |
|
| 8 | Diammonium Glycyrrhizinate |
| 10 mg/kg per day, i.p. | Attenuate the memory deficits and suppress Aβ1–42-induced activation of microglia and inflammation | Attenuate Aβ1–42-induced neuroinflammation and regulate MAPK and NF-κB pathways | SH-SY5Y and HT-22 cells or male ICR mice |
|
TCM for treating AD by reducing oxidative stress.
| Numbers | Compounds | Chemistry structure | Dosages | Activities | Molecular mechanism | Models | References |
|---|---|---|---|---|---|---|---|
| 1 | Schisanhenol |
| 10–100 mg/kg | Improve learning memory and attenuate oxidative damage | Reduce acetylcholinesterase activity and attenuate oxidative damage through SIRT1-PGC-1α-Tau signaling pathway | Scopolamine-treated Kunming mice |
|
| 2 | Amentoflavone |
| 80 mg/kg | Ameliorate memory deficits and oxidative stress | Ameliorate memory deficits and oxidative stress by inducing Nrf2 antioxidant pathways | PC12 cells and rat |
|
| 3 | Coptis chinensis Franch. watery extract | — | 100 mg/mL | Neuroprotective and against oxidative stress | Have neuroprotective and against oxidative stress and down regulation of TXNIP | SHSY5Y cells | Thomas |
| 4 | Oxymatrine |
| 30–120 mg/kg | Increase cell viability and SOD activity | Improve the cognitive ability of rats and has a protective effect on Aβ1-42-induced primary neuronal cell by inhibiting MAPK and NF-κB signal pathways | Sprague-Dawley rats |
|
| 5 | Shikonin |
| 3.47, 10.42, 34.72 µM | Improve cell viability, decrease the MDA and ROS content, and stabilize the mitochondrial membrane potential | Reduce the activity of caspase-3 and moderate the ratio of Bcl-2/Bax through antioxidant and antiapoptotic activities | PC12 cells |
|
| 6 | Linalool |
| 100 mg/kg per day, i.p. | Improve the cognitive performance and reverse the Aβ1-40 induced hippocampal cell injury, apoptosis and changes of oxidative stress indicators | Alleviate apoptosis, oxidative stress | C57BL/6J mice |
|
| 7 | Schisandrin C |
| 150 μg/kg, 10 mL/kg, injection | Improve the cognitive function and working memory | Inhibit ChEtotal, increased SOD and GSH-px, GSH | Male Kunming mice |
|
| 8 | Acteoside |
| 30, 60, and 120 mg/kg/day, for 30 days | Attenuate cognitive impairment and increase the numbers of neurons and Nissl bodies | Decrease the content of NO, the activity of NOS and the expression of caspase-3 protein due to oxidative stress | Kunming mice |
|
| 9 | Vanillic acid |
| 50 and 100 mg/kg | Improve spatial learning and memory | Improve the habituation memory, decrease the AChE, corticosterone, TNF-α by preventing oxidative stress | Swiss albino male mice |
|
| 10 | Protosappanin A |
| 10 mg/kg, 5–50 μM | Inhibit ROS and NO production by suppression of NADPH oxidase and iNOS activity | Modulate IKK/IκB/NF-κB inflammation signal pathway to inhibit the activity and expressions of NADPH oxidase and iNOS | BV-2 cells or ICR mice | Ze |
| 11 | Salidroside |
| 10, 50, 100 mM | Protect neurons from oxidative stress | Inhibit Aβ25–35-induced phosphorylation of JNK and p38 MAP kinase and oxidative stress. | SH-SY5Y cells |
|
TCM for treating AD by reducing mitochondrial dysfunction.
| Numbers | Compounds | Chemistry structure | Dosages | Activities | Molecular mechanism | Models | References |
|---|---|---|---|---|---|---|---|
| 1 | Icariin |
| 65 mg/kg, 20 μmol/kg/day | Improve spatial learning and memory retention | Ameliorate Aβ elevation in mitochondria and regulate the activity and expression of key mitochondrial enzymes | 3 × Tg-AD mice |
|
| 2 | Salvianolic acid B |
| 50 μM | Inhibit axonal mitochondrial fragmentation | Attenuate axonal mitochondrial fragmentation and increase kinesin-like protein 1 phosphorylation and restore the synaptic density | Primary cultured mouse neurons cell |
|
| 3 | Ligustilide |
| 10 or 40 mg/kg | Reduce the level of Drp1 and increase levels of Mfn1, Mfn2, and Opa1 | Exerts an antioxidation effect | The APPswe/PS1dE9 (APP/PS1) transgenic mouse |
|
| 4 | Tetrahydroxy stilbene glycoside |
| 100 μg/mL, 5, 10, 30, 60, 90 μmol/L | Alleviate cell oxidative stress injury and mitochondrial membrane potential | Restore Aβ-induced hippocampal neuronal cell damage by restoring mitochondrial function | HT-22 cell |
|
| 5 | Hopeahainol A |
| 4 mg/kg/day | Attenuate memory deficits | Reduce mitochondrial dysfunction and oxidative stress | APP/PS1 transgenic mice |
|
TCM for treating AD by other ways.
| Numbers | Compounds | Chemistry structure | Dosages | Activities | Molecular mechanism | Models | References |
|---|---|---|---|---|---|---|---|
| 1 | Osthole |
| 10–100 μM | Decrease Aβ levels | Decrease Aβ levels though up-regulation of miR-107 | APP/PS1 transgenic mice and SH-SY5Y cells, HEK293 cell |
|
| 2 | Dendrobium officinale polysaccharides | — | 5–10 μg/mL | Attenuate cognitive impairment | Attenuate cognitive impairment | BV2 cells, SAMP8 mice |
|
Figure 3Mechanism in treating AD based on monomer and extract of TCM.